Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 8/20 | 0.55 |
| ▸ | CES1 | P23141 | 8/20 | 0.55 |
| ▸ | CES2 | O00748 | 5/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | PPARG | P37231 | 5/20 | 0.46 |
| ▸ | PPARD | Q03181 | 5/20 | 0.46 |
| ▸ | PPARA | Q07869 | 5/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6120075 | 1.00 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL28986780 | 1.00 | FAAH (0.55) | FAAHCES1CES2MEN1KMT2A | |
| Ethylene Glycol SCHEMBL28018645 | 0.94 | FAAH (0.50) | FAAHCES1CES2MEN1KMT2A | |
| Chloroform SCHEMBL25199245 | 0.93 | FAAH (0.48) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL723655 | 0.89 | FAAH (0.63) | FAAHCES1MEN1KMT2AHSD17B10 | |
| SCHEMBL29072795 | 0.89 | FAAH (0.63) | FAAHCES1MEN1KMT2AHSD17B10 | |
| SCHEMBL3415485 | 0.83 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL3777162 | 0.83 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL9435633 | 0.83 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A | |
| SCHEMBL3777756 | 0.83 | FAAH (0.59) | FAAHCES1CES2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015412-A | Nanometer photosensitizer and application thereof in echinococcosis | 兰州大学 | 2024-11-26 | — | — | CN | claimed |
| EP-0596024-A4 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS. | VESTAR INC (US) | 1996-07-17 | — | — | EP | claimed |
| EP-0596024-A1 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS | NeXstar Pharmaceuticals, Inc. (US) | 1994-05-11 | — | — | EP | claimed |
| WO-1993001828-A1 | LIPID CONJUGATES OF THERAPEUTIC PEPTIDES AND PROTEASE INHIBITORS | VICAL, INC. (US) | 1993-02-04 | — | — | WO | claimed |
| CN-117551160-B | Application of pentacyclic triterpene compounds in treatment of neurodegenerative diseases | 中国医学科学院药物研究所 | 2026-05-15 | — | — | CN | disclosed |
| CN-117567544-B | Application of pentacyclic triterpene compounds with alpha, beta-unsaturated ketone structures in preventing and treating neurodegenerative diseases | 中国医学科学院药物研究所 | 2026-05-15 | — | — | CN | disclosed |
| EP-4004548-B1 | METHODS OF TREATING AND DIAGNOSING LUNG CANCER | YEDA RES & DEV (IL) | 2026-01-14 | — | — | EP | disclosed |
| US-20250354993-A1 | METHODS OF TREATING AND DIAGNOSING LUNG CANCER | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2025-11-20 | — | — | US | disclosed |
| EP-4622629-A1 | METHOD FOR TREATING AND/OR PREVENTING EDEMATOUS FIBROSCLEROTIC PANNICULOPATHY | Caliway Biopharmaceuticals Co. Ltd. (TW) | 2025-10-01 | — | — | EP | disclosed |
| CN-114015692-B | Complement component C5 iRNA compositions and methods of use thereof | 阿尔尼拉姆医药品有限公司 | 2024-12-31 | — | — | CN | disclosed |
| CN-119015412-A | Nanometer photosensitizer and application thereof in echinococcosis | 兰州大学 | 2024-11-26 | — | — | CN | disclosed |
| CN-115246868-B | Application of pentacyclic triterpene compounds in treatment of neurodegenerative diseases | 中国医学科学院药物研究所 | 2024-06-21 | — | — | CN | disclosed |
| US-6071533-A | Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2000-06-06 | — | — | US | disclosed |
| EP-0912198-A4 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | UNIV CALIFORNIA (US) | 2000-04-12 | — | — | EP | disclosed |
| WO-1999058694-A1 | METHODS OF FORMING PROTEIN-LINKED LIPIDIC MICROPARTICLES, AND COMPOSITIONS THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-11-18 | — | — | WO | disclosed |
| EP-0956001-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT $i(IN VIVO) DELIVERY | The Regents of the University of California (US) | 1999-11-17 | — | — | EP | disclosed |
| EP-0912198-A1 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1999-05-06 | — | — | EP | disclosed |
| WO-1998020857-A1 | PREPARATION OF STABLE FORMULATIONS OF LIPID-NUCLEIC ACID COMPLEXES FOR EFFICIENT IN VIVO DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1998-05-22 | — | — | WO | disclosed |
| WO-1997038731-A1 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1996014864-A1 | IMMUNOLIPOSOMES THAT OPTIMIZE INTERNALIZATION INTO TARGET CELLS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-05-23 | — | — | WO | disclosed |